Maker of promising Alzheimer’s drug Leqembi expects full FDA approval this summer, expanded Medicare coverage
Tek Image/science Photo Library | Science Photo Library | Getty Images Japanese drugmaker Eisai expects the Food and Drug Administration to fully approve its Alzheimer’s treatment Leqembi this summer, which…